Plasma melatonin levels in patients with diabetic retinopathy secondary to type 2 diabetes
Wen-Cui Wan, Yang Long, Wei-Wei Wan, Hong-Zhuo Liu, Hao-Hao Zhang, Wei Zhu
Wen-Cui Wan, Yang Long, Wei-Wei Wan, Hong-Zhuo Liu, Wei Zhu, Department of Ophthalmology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan Province, China
Hao-Hao Zhang, Department of Endocrinology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan Province, China
Wei Zhu, Department of Ophthalmology, Changshu No. 2 People's Hospital, Changshu 215000, Jiangsu Province, China
Author contributions: Wan W,Long Y and Zhang HH contributed equally to this work; Wan W, Long Y, Wan W, Liu H, Zhang H and Zhu W designed the research study; Wan W, Long Y, Wan W, Liu H and Zhang H performed the research; Wan W, Long Y, Wan W and Zhu W contributed new reagents and analytic tools; Wan W, Long Y and Wan W analyzed the data and wrote the manuscript; all authors have read and approved the final manuscript.
Supported by National Nature Science Foundation Project for Young Scientists of China, No. 81700804; The Foundation for Young Medical Talents of Jiangsu Province, No. QNRC2016211; Scientific Research Project of Jiangsu Health Commission, No. Z2019044; and Youth Project of Henan Provincial Health and Health Commission, Ministry of Education, No. SB201902008.
Institutional review board statement: The study was reviewed and approved by the Ethical Committee of the Changshu No. 2 People’s Hospital (Approval No. 2020-KY-003).
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: The authors report no conflicts of interest.
Data sharing statement: No additional data are available.
STROBE statement: The authors have read the STROBE Statement-checklist of items, and the manuscript was prepared and revised according to the STROBE Statement-checklist of items.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:
http://creativecommons.org/Licenses/by-nc/4.0/ Corresponding author: Wei Zhu, MD, Attending Physician, Department of Ophthalmology, Changshu No. 2 People's Hospital, No. 99 Xiannan Street, Changshu 215000, Jiangsu Province, China.
shzhuwei0722@163.com
Received: August 2, 2020
Peer-review started: August 2, 2020
First decision: November 18, 2020
Revised: November 26, 2020
Accepted: December 10, 2020
Article in press: December 10, 2020
Published online: February 15, 2021
Processing time: 174 Days and 1.4 Hours
